|
NCT03800212
|
Study of Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma (AMPULLOMA)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03755726
|
A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort (HAMA)
|
En recrutement
|
20 mars 2023
|
|
NCT02534649
|
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials (BIP)
|
En recrutement
|
20 mars 2023
|
|
NCT02377583
|
Hypothalamo-pituitary Adrenal Axis Activity: Relation With Neuropsychological Consequences in Type 1 Diabetes in Childhood. The CORTICODIAB Study (CORTICODIAB)
|
Statut inconnu
|
20 mars 2023
|
|
NCT02355379
|
Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi (ADAGE)
|
En recrutement
|
20 mars 2023
|
|
NCT02066454
|
Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study (MYELAXAT)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03306251
|
ANRS CO11 : National Cohort of Children Born to HIV-positive Mothers (EPF)
|
En recrutement
|
20 mars 2023
|
|
NCT02416388
|
Phase II/III Randomized Study to Improve Overall Survival in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus Mycophenolate Mofetil Prophylaxis of Graft Versus Host Disease in Allografted Patients in First CR : a Backbone InterGroup-1 Trial (BIG-1)
|
En recrutement
|
20 mars 2023
|
|
NCT00443339
|
A Phase II Study of Darbepoetin Alpha in Myelodysplastic Syndromes (MSD)
|
Statut inconnu
|
29 octobre 2022
|